Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2021 | Interius BioTherapeutics | $76.0M Series A | Cormorant Asset Management, Tomas Kiselak | Agent Capital, Bain Capital Life Sciences, Cofounders Capital, American Cancer Society, BrightEdge, Knollwood Investment Advisory, Logos Capital, Longwood Fund, Osage University Partners, RA Capital Management, Lonnie Moulder Jr, The Mark Foundation for Cancer Research, University of Pennsylvania |